No Data
No Data
Control Bionics Raises AU$130,000 via Additional Commitments for Placement
Medical device company Control Bionics (ASX:CBL) received additional commitments of AU$130,000 for a placement. An additional 3,023,258 ordinary shares will be issued at AU$0.043 apiece, according to
Control Bionics to Raise AU$1 Million via Share Placement
Control Bionics (ASX:CBL) secured firm commitments from professional and sophisticated investors to raise AU$1.04 million, before costs, the medical device company said in a Wednesday filing with the
Control Bionics Appoints Corporate Advisor
Medical device company Control Bionics (ASX:CBL) appointed Lynx Advisors as its corporate advisor, according to a Monday filing with the Australian Securities Exchange. Lynx Advisors is a boutique inv
Control Bionics Appoints CFO
Medical device company Control Bionics (ASX:CBL) named Shannon Boothroyd as chief financial officer, effective May 13, according to a Thursday filing with the Australian Securities Exchange. Boothroyd
Control Bionics Signs Multiple Award Schedule Contract With US Government
Control Bionics (ASX:CBL) obtained a multiple award schedule contract from the US General Services Administration, unlocking direct access to various government buyers to sell its Trilogy solution, ac
Australian Shares Jump to More Than Three-Week High as Central Bank Holds Rates
Australian shares rose to a more than three-week high on Tuesday after the country's central bank kept rates steady as inflation eases at a slower-than-expected rate. The S&P/ASX 200 Index surged 110.
No Data
SurfingSam : Thanks